Arvinas (ARVN) Capital Expenditures (2017 - 2026)

Arvinas' (ARVN) quarterly Capital Expenditures came in at $1.3 million in Q1 2026, up 225.0% year-on-year from $400000.0 in Q1 2025, and up 192.86% quarter-over-quarter from -$1.4 million in Q4 2025.

Arvinas (ARVN) Capital Expenditures (2017 - 2026) Analysis & Trends

Arvinas' Capital Expenditures history runs 10 years deep, the most recent figure standing at $1.3 million for Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 225.0% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 45.45% decrease from a year earlier, with the FY2025 full-year figure at $300000.0, down 83.33% from the prior year.
  • Capital Expenditures grew to $1.3 million in Q1 2026 per ARVN's latest filing, from -$1.4 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $2.1 million in Q1 2022 and bottomed at -$1.6 million in Q2 2022.
  • The 5-year median for Capital Expenditures is $500000.0 (2023), against an average of $400000.0.
  • Across the five-year window, Capital Expenditures soared 650.0% in 2023 and tumbled 566.67% in 2025, its largest moves.
  • Year by year, Capital Expenditures stood at -$200000.0 in 2022, then jumped by 150.0% to $100000.0 in 2023, then soared by 200.0% to $300000.0 in 2024, then tumbled by 566.67% to -$1.4 million in 2025, then surged by 192.86% to $1.3 million in 2026.
  • Per Business Quant, the three latest ARVN Capital Expenditures figures stand at $1.3 million (Q1 2026), -$1.4 million (Q4 2025), and $100000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 43.25 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 133.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 230.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 786,000.00
10 Arvinas 519.68 Mn -95.22 Mn - 1.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.30 Mn
Mar 31, 2026 1.30 Mn
Dec 31, 2025 -1.40 Mn
Dec 31, 2025 -1.40 Mn
Sep 30, 2025 100,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 1.20 Mn
Jun 30, 2025 1.20 Mn
Mar 31, 2025 400,000.00
Mar 31, 2025 400,000.00
Dec 31, 2024 300,000.00
Dec 31, 2024 300,000.00
Sep 30, 2024 700,000.00
Sep 30, 2024 700,000.00
Jun 30, 2024 800,000.00
Jun 30, 2024 800,000.00
Dec 31, 2023 100,000.00
Dec 31, 2023 100,000.00
Sep 30, 2023 1.10 Mn
Sep 30, 2023 1.10 Mn